XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2020 $ 1,910,528 $ 7,175 $ 314,056 $ (756,842) $ 2,335,216 $ 10,923
Beginning balance (in shares) at Dec. 31, 2020   100,447        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 72,293       72,297 (4)
Other comprehensive income/(loss):            
Translation gain (loss) (32,541)     (32,021)   (520)
Defined benefit plan adjustment, net of tax 5,385     5,385    
Derivative financial instruments, net of tax 958     958    
Other comprehensive income/(loss) (26,198)     (25,678)   (520)
Dividends (45,510)       (45,510)  
Issuance of stock awards 364   364      
Issuance of stock awards (in shares)   245        
Shares repurchased (5,051)   (5,051)      
Shares repurchased (in shares)   (85)        
Share-based compensation 6,372   6,372      
Ending Balance at Apr. 04, 2021 1,912,798 $ 7,175 315,741 (782,520) 2,362,003 10,399
Ending balance (in shares) at Apr. 04, 2021   100,607        
Beginning Balance at Dec. 31, 2020 1,910,528 $ 7,175 314,056 (756,842) 2,335,216 10,923
Beginning balance (in shares) at Dec. 31, 2020   100,447        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) (261,946)          
Other comprehensive income/(loss):            
Translation gain (loss) (19,945)          
Defined benefit plan adjustment, net of tax 428,130          
Derivative financial instruments, net of tax 4,440          
Other comprehensive income/(loss)       412,386    
Ending Balance at Jul. 04, 2021 1,822,433 $ 7,175 166,295 (344,456) 1,982,430 10,989
Ending balance (in shares) at Jul. 04, 2021   98,829        
Beginning Balance at Apr. 04, 2021 1,912,798 $ 7,175 315,741 (782,520) 2,362,003 10,399
Beginning balance (in shares) at Apr. 04, 2021   100,607        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) (334,239)       (334,070) (169)
Other comprehensive income/(loss):            
Translation gain (loss) 12,596     11,837   759
Defined benefit plan adjustment, net of tax 422,745     422,745    
Derivative financial instruments, net of tax 3,482     3,482    
Other comprehensive income/(loss) 438,823     438,064   759
Dividends (45,503)       (45,503)  
Issuance of stock awards 246   246      
Issuance of stock awards (in shares)   41        
Shares repurchased (154,519)   (154,519)      
Shares repurchased (in shares)   (1,819)        
Share-based compensation 4,827   4,827      
Ending Balance at Jul. 04, 2021 1,822,433 $ 7,175 166,295 (344,456) 1,982,430 10,989
Ending balance (in shares) at Jul. 04, 2021   98,829        
Beginning Balance at Dec. 31, 2021 $ 1,849,541 [1] $ 7,175 119,690 (359,425) 2,070,005 12,096
Beginning balance (in shares) at Dec. 31, 2021 97,370 97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 115,607       115,333 274
Other comprehensive income/(loss):            
Translation gain (loss) 706     (185)   891
Defined benefit plan adjustment, net of tax 191     191    
Derivative financial instruments, net of tax 2,550     2,550    
Other comprehensive income/(loss) 3,447     2,556   891
Dividends (44,124)       (44,124)  
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Issuance of stock awards 377   377      
Issuance of stock awards (in shares)   182        
Shares repurchased (3,410)   (3,410)      
Shares repurchased (in shares)   (60)        
Share-based compensation 10,689   10,689      
Ending Balance at Apr. 03, 2022 1,918,931 $ 7,175 120,266 (356,869) 2,141,214 7,145
Ending balance (in shares) at Apr. 03, 2022   97,492        
Beginning Balance at Dec. 31, 2021 $ 1,849,541 [1] $ 7,175 119,690 (359,425) 2,070,005 12,096
Beginning balance (in shares) at Dec. 31, 2021 97,370 97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 247,374          
Other comprehensive income/(loss):            
Translation gain (loss) (69,608)          
Defined benefit plan adjustment, net of tax (1,737)          
Derivative financial instruments, net of tax 460          
Other comprehensive income/(loss)       (71,252)    
Purchase of noncontrolling interest     (7,080)      
Ending Balance at Jul. 03, 2022 $ 1,936,391 [1] $ 7,175 128,332 (430,677) 2,224,845 6,716
Ending balance (in shares) at Jul. 03, 2022 97,495 97,495        
Beginning Balance at Apr. 03, 2022 $ 1,918,931 $ 7,175 120,266 (356,869) 2,141,214 7,145
Beginning balance (in shares) at Apr. 03, 2022   97,492        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 131,767       131,672 95
Other comprehensive income/(loss):            
Translation gain (loss) (70,314)     (69,790)   (524)
Defined benefit plan adjustment, net of tax (1,928)     (1,928)    
Derivative financial instruments, net of tax (2,090)     (2,090)    
Other comprehensive income/(loss) (74,332)     (73,808)   (524)
Dividends (48,041)       (48,041)  
Issuance of stock awards 263   263      
Issuance of stock awards (in shares)   13        
Shares repurchased (574)   (574)      
Shares repurchased (in shares)   (10)        
Share-based compensation 8,377   8,377      
Ending Balance at Jul. 03, 2022 $ 1,936,391 [1] $ 7,175 $ 128,332 $ (430,677) $ 2,224,845 $ 6,716
Ending balance (in shares) at Jul. 03, 2022 97,495 97,495        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the "United States" or "U.S.").